In 2021, a greater number of global pulmonary arterial hypertension cases occurred in females vs. males, and disease prevalence reached its highest point at age 75 to 79 years, according to data ...

Resverlogix Corp. (TSX: RVX) ("Resverlogix", or the "Corporation") today held its Annual Meeting of Shareholders (the ...

Previous knowledge on melatonin use for pulmonary arterial hypertension has primarily been gathered from animal studies, with ...

Cite this: Top Ten List in Pulmonary Vascular Disease - Medscape - Feb 01, 2005. Pulmonary Arterial Hypertension Guidelines Genetics and Pathophysiology of Pulmonary Vasculopathies ...

At 12 weeks, patients treated with ENV-101 showed statistically significant increases in lung volume compared with those ...

Pulmonary vascular diseases, which include pulmonary hypertension and pulmonary embolism, concern the organ’s blood vessels. While there is no cure, ...

Long-term exposure to particulate matter in patients with pulmonary arterial hypertension increases risk for lung transplantation or death.

Shares of Insmed jumped Tuesday after the biopharmaceutical firm reported positive results from a Phase 2 trial for its ...

BMPER attenuated PI3K/AKT signaling and suppressed BMP4-driven smooth muscle activation in models of PAH. BMPER overexpression mitigated the vascular remodeling that characterizes pulmonary arterial ...

A Phase 3 clinical trial testing the experimental daily oral treatment ralinepag in people with PAH has completed enrollment.

In PAH, pulmonary rehabilitation referral and participation rates are low and are significantly affected by demographic and socioeconomic factors.

Emphysema subtypes, identified via CT, may be linked to cardiopulmonary subphenotypes that can help to target cardiac care in early COPD.